Skip to main content
Fig. 8 | BMC Cancer

Fig. 8

From: Global retrospective analysis of clinician- and patient-reported clinical characteristics and humanistic burden of patients with gastroesophageal cancers on first-line treatment

Fig. 8

Drivers of FACT-G in patients with GC/GEJC/EAC, HER2 negative/unknown, on first-line treatment. EAC, esophageal adenocarcinoma; ECOG, Eastern Cooperative Oncology Group; FACT-G, Functional Assessment of Cancer Therapy-General; GC, gastric cancer; GEJC, gastroesophageal junction cancer. * p < 0.05, † base category. Respiratory symptoms include chest infection, shortness of breath, chest pain, persistent coughing, pleural effusion, sputum. Other symptoms include weakness and fatigue, jaundice, acute bleeding, headaches, anemia, other pain, other

Back to article page